Accendra HealthACH +2.24%57 Beneish M-Score is -5.13 as of Jun. 25, 2026. GuruFocus rates ACH with a GF Score™ of 57/100 and a GF Value™ of $5.02 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 113 Medical Distribution companies, Accendra Health ranks better than 97.35% on this metric.
The zones of discrimination for M-Score is as such:
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Good Sign:
Beneish M-Score -5.13 no higher than -1.78, which implies that the company is unlikely to be a manipulator.
The historical rank and industry rank for Accendra Health's Beneish M-Score or its related term are showing as below:
ACH'
s Beneish M-Score Range Over the Past 10 Years
Min: -5.13 Med: -2.46 Max: 6.52
Current: -5.13
During the past 13 years, the highest Beneish M-Score of Accendra Health was 6.52. The lowest was -5.13. And the median was -2.46.
Accendra Health Beneish M-Score Related Terms
Accendra Health Beneish M-Score Historical Data
* Premium members only.
The historical data trend for Accendra Health's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Accendra Health's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accendra Health Beneish M-Score vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Accendra Health's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where Accendra Health's Beneish M-Score falls into.
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Accendra Health for today is based on a combination of the following eight different indices:
M
=
-4.84
+
0.92 * DSRI
+
0.528 * GMI
+
0.404 * AQI
+
0.892 * SGI
+
0.115 * DEPI
=
-4.84
+
0.92 * 0.3076
+
0.528 * 0.7015
+
0.404 * 1.7236
+
0.892 * 0.581
+
0.115 * 0.3644
-
0.172 * SGAI
+
4.679 * TATA
-
0.327 * LVGI
-
0.172 * 1.432
+
4.679 * -0.322922
-
0.327 * 1.3423
=
-5.13
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
DEPI
=
(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))
/
(Depreciation_t / (Depreciaton_t + PPE_t))
=
(168.339 / (168.339 + 903.443))
/
(249.776 / (249.776 + 329.699))
=
0.157065
/
0.431038
=
0.3644
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
TATA
=
(IncomefromContinuingOperations_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(NetIncome_t - NonOperatingIncome_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(-1082.128 - -185.153
-
-116.801)
/
2415.982
=
-0.322922
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Accendra Health has a M-score of -5.13 suggests that the company is unlikely to be a manipulator.
Accendra Health (ACH) has a Beneish M-Score of -5.13 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Accendra Health and its competitors. According to the industry distribution chart, Accendra Health ranks #3 out of 113 companies in the Medical Distribution industry, placing it in the top 2.7%.
Is Accendra Health's Beneish M-Score too high?
Accendra Health's current Beneish M-Score is -5.13. Based on the distribution chart, Accendra Health ranks #3 out of 113 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Accendra Health has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's Beneish M-Score compare to EDAP and YI?
According to the Medical Distribution industry distribution chart, Accendra Health ranks #3 out of 113 companies for Beneish M-Score. This places Accendra Health in the top 3% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Distribution company?
A good Beneish M-Score depends on the Medical Distribution industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Accendra Health and its competitors. Accendra Health's current Beneish M-Score is -5.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Based on GuruFocus' analysis, Accendra Health (ACH) is currently considered Possible Value Trap. The stock's GF Value™ is $5.02, compared to a current price of $3.20 — trading 36.3% below its estimated fair value. The current Beneish M-Score is -5.13. Accendra Health's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Accendra Health (ACH), the current Beneish M-Score is -5.13 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Accendra Health (ACH) Overvalued in 2026?
Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued.
The current stock price of $3.20 is trading 36.3% below its estimated GF Value™ of $5.02.
GuruFocus considers Accendra Health to be Possible Value Trap.
Key valuation signals for ACH:
Beneish M-Score: -5.13
GF Value™: $5.02 vs. price of $3.20 (36.3% below fair value)
No single metric tells the full story. See the ACH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
57GF Score
Get the complete analysis for ACH
Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACH has been successfully added to your 
